Madworks and gener8tor’s gBETA program in Madison both wrapped up their fall sessions recently. That means a total of 10 local startups have gone through the paces and come out with a new understanding of how to make a mark in today’s business world. At Madworks,...
Researchers at the University of Wisconsin–Madison are investigating cross-talk between the brain and lungs of people with asthma in a four-year, $2.5 million study to understand how psychological stress can make asthma symptoms worse. Through a clinical study called AsthMatic Inflammation and Neurocircuitry Activation, or MINA,...
Coenzyme Q (CoQ) is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. But six decades removed from its discovery, scientists still can’t describe exactly how and when it is made. Dave Pagliarini, director...
Madison-area business leaders are seeing an influx of millennial talent as a result of the region’s growing tech ecosystem. “It’s a very exciting time,” says Jeff Naughton, site director for Google Madison. He spoke at a “State of the Sector” event put on yesterday by the...
As a child, Rachel Rose wore clothes emblazoned with C-3PO and drifted off to sleep on Star Wars sheets. And while the adventures of Luke Skywalker, Princess Leia and the Jedi knights may have filled her dreams, she never imagined she’d grow up to help...
The National Science Foundation released its 2016 Higher Education Research and Development (HERD) Survey data, showing that UW–Madison retained 6th place in the national research rankings. Data on UW–Madison’s 2016 expenditures for research show the university remains a research powerhouse with nearly $1.16 billion in annual...
Exact Sciences CFO Jeff Elliott says the foundation laid with Cologuard will help bring to market other screening tools, such as a lung cancer test. Elliott gave a promising update on Cologuard and laid out the Madison-based company’s plans at a recent Wisconsin Technology Council luncheon...
WARF's Managing Director, Erik Iverson, discusses innovation, commercialization, and his organization's contributions to the Wisconsin Idea....
Republican and Democratic legislators are backing a bill designed to make it easier for University of Wisconsin employees to privately fund and commercialize their research. Rep. Dave Murphy, R-Greenville, chair of the Assembly Colleges and Universities Committee, and former Sen. Sheila Harsdorf, R-River Falls, chair of...
For the past five years, CRISPR-Cas9 technology has revolutionized the field of gene editing due to its ease and low cost. But although this technology reliably finds and cuts the targeted stretch of DNA sequence, fixing that cut as desired has been something of a...
The degenerative brain disease associated with aging, Alzheimer’s, is a long-standing mystery in the medical world. With 5 million people living with Alzheimer’s disease in the United States alone, new approaches are being taken to discover the unknown causes of the condition. Craig Atwood, founder of...
In his UW-Madison lab, Su-Chun Zhang discovered a likely cause of ALS, the deadly neurological disorder also known as Lou Gehrig’s disease, after turning skin cells from ALS patients into stem cells. A protein error in cellular structures called neurofilaments, which transport chemicals that allow muscles...